Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Maravai LifeSciences Holdings, Inc. - Class A common stock (NQ:MRVI)

6.670 -0.390 (-5.52%)
Delayed Quote Updated: 2:28 PM EDT, Oct 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

All News about Maravai LifeSciences Holdings, Inc. - Class A common stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
News headline image
Maravai LifeSciences (MRVI) Q4 2023 Earnings Call Transcript ↗
MRVI earnings call for the period ending December 31, 2023. 
Via The Motley Fool
Topics Earnings
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Recap: Maravai LifeSciences Q4 Earnings ↗
 
Via Benzinga
News headline image
Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results
Continued Focus on Expanding Product Portfolio, Market Leadership and Innovation 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
TriLink BioTechnologies® Solidifies IP Position with Awarded Patents for CleanCap® Capping Technology in China and Canada
From TriLink BioTechnologies
Via Business Wire
News headline image
7 Analysts Have This to Say About Maravai LifeSciences ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 22, 2024 ↗
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million. 
Via Benzinga
Nasdaq Stocks Are Taking Center Stage This Week! DYAI, MRVI, SPWR, VTAK, KAVL, INBS
Via AB Newswire
Biopharmaceutical Advancements: Dyadic (Nasdaq: DYAI) Raises Industry Standards with Maravai LifeSciences’ (Nasdaq: MRVI) Cygnus Technologies
Via AB Newswire
News headline image
Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
3 Doomed Biotech Stocks to Dump Before They Dive: February 2024 ↗
Spot the looming risks in the biotech sector and avoid these three doomed biotech stocks likely to burn shareholder value significantly. 
Via InvestorPlace
News headline image
Maravai LifeSciences To Host Earnings Conference Call on Thursday, February 22, 2024
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
Tech Drags On Wall Street As 2024 Kicks Off; Dollar and Treasury Yields Surge: What's Driving Markets Tuesday? ↗
Wall Street kicked off 2024 on a weaker note, with the S&P 500 dipping by 0.5%, and the Nasdaq 100 experiencing a 1.4% decline in midday trading in New York. 
Via Benzinga
News headline image
Stocks Edge Higher, 'Fear Index' Plummets To Nearly 3-Year Lows Ahead Of Fed Meeting: What's Driving Markets Tuesday? ↗
The U.S. 
Via Benzinga
Topics Economy
News headline image
Maravai LifeSciences Announces November 2023 Investor Conference Schedule
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Toast Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares climbed 96% to $0.2921 after falling over 7% on Tuesday. 
Via Benzinga
News headline image
Maravai LifeSciences (MRVI) Q3 2023 Earnings Call Transcript ↗
MRVI earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Maravai LifeSciences Reports Third Quarter 2023 Financial Results
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
TriLink BioTechnologies® Expands Capabilities with Launch of ‘Analytical Sciences Center of Excellence’
From TriLink BioTechnologies
Via Business Wire
News headline image
Maravai LifeSciences To Host Earnings Conference Call on Tuesday, November 7, 2023
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
Maravai LifeSciences Hosts 2023 Investor R&D Day
Highlights include the company’s strong foundation for growth, focus on innovation and attractive long-term outlook 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
Maravai LifeSciences Chief Innovation Officer Kate Broderick Named to 2023 PharmaVoice 100
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
Maravai LifeSciences to Host 2023 Investor R&D Day
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
Cygnus Technologies Receives 2023 R&D 100 Award for MockV® RVLP Kit
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
Maravai LifeSciences Announces August 2023 Investor Conference Schedule
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023 ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Hims & Hers Health Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket ↗
Gainers Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) shares surged 83.5% to $0.1648 in pre-market trading after falling over 25% on Monday. The company recently announced its plans to reduce the... 
Via Benzinga
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.